Connect with us

Stock News

Eli Lilly’s stock dives as Mounjaro and Zepbound sales miss, but Citi says buy

Published

2 months ago

on


Eli Lilly’s stock heads for biggest selloff in more than 4 years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Related Topics:
Continue Reading

Stock News

Treasury yields trim declines after PCE inflation reading edges up from Fed’s target

Published

4 weeks ago

on

November 27, 2024

By

Treasury yields were trimming earlier declines after a barrage of pre-Thanksgiving economic data added to the case for gradual Fed rate cuts .

Continue Reading

Stock News

Jobless claims slide to 7-month low. Businesses not cutting many jobs.

Published

4 weeks ago

on

November 27, 2024

By


The number of Americans who applied for unemployment benefits in the week before the Thanksgiving holiday dipped to a seven-month low in a sign of strength for a steadily expanding U.S. economy.

Continue Reading

Stock News

More turnover at the top, but this bull still believes in the Weight Watchers parent

Published

4 weeks ago

on

November 27, 2024

By


D.A. Davidson reckons WW is a buy as its customers need more than a prescription.

Continue Reading

Trending